8. According to the article, which statement is true?

Answer: C

Explanation:

James P. Allison and Tasuku Honjo have discovered new relationships between certain proteins and cancer.

Their research has focused on uncovering new strategies for inhibiting the negative regulation of immune responses, particularly through T-cell immunotherapy, which involves understanding the roles of specific proteins like CTLA-4 and PD-1 in the immune system's fight against cancer.

A) CTLA-4 and PD-1 are two types of cancer that have been cured by CTLA-4 and PD-1.

This statement is incorrect as CTLA-4 and PD-1 are not types of cancer; rather, they are proteins that play crucial roles in regulating immune responses. The research conducted by Allison and Honjo involves these proteins in the context of immunotherapy, not curing cancers directly.

B) All cancers have been cured by James P. Allison and Tasuku Honjo's therapeutic practices.

This statement is false. While Allison and Honjo have made significant contributions to cancer immunotherapy, their work has not led to the cure of all cancers. Their research has improved treatment strategies, but cancer remains a leading cause of mortality worldwide.

C) James P. Allison and Tasuku Honjo have discovered new relationships between certain proteins and cancer.

This statement is true as their research aims to uncover how proteins like CTLA-4 and PD-1 affect immune responses to cancer. This has led to innovative approaches in immunotherapy, highlighting the importance of these proteins in cancer treatment.

D) James P. Allison and Tasuku Honjo just recently started studying cancer.

This statement is incorrect. Both researchers have been involved in cancer research for several decades, and their recent work has built on years of foundational knowledge in the field, leading to significant advancements in immunotherapy.

Conclusion

Option C is the only accurate statement, as it reflects the true nature of Allison and Honjo's groundbreaking research, which focuses on the relationship between specific proteins and cancer treatment. All other options either misrepresent their contributions or inaccurately describe the state of cancer research and treatment.